About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Bank of England's rate decision was approved by a 6-3 vote, unchanged from the prior meeting. Monetary Policy Committee members Ge Lin, Mann and Chief Economist Pill voted for a rate hike.

2026-09-17

Bank of England's rate decision was approved by a 6-3 vote, unchanged from the prior meeting. Monetary Policy Committee members Ge Lin, Mann and Chief Economist Pill voted for a rate hike.

Other News
2026-09-17

Japan's Health, Labor and Welfare Minister Ken'ichiro Ueno is reportedly set to retain his post in the upcoming cabinet reshuffle.

Japan's Health, Labor and Welfare Minister Ken'ichiro Ueno is reportedly set to retain his post in the upcoming cabinet reshuffle.
2026-09-17

Key News 1. The Hong Kong Monetary Authority (HKMA) issued a statement announcing a 25 basis point increase in its benchmark interest rate to 4.25%. Individual Stock News 1. Leapmotor (09863.HK) received formal approval from the China Securities R

Key News 1. The Hong Kong Monetary Authority (HKMA) issued a statement announcing a 25 basis point increase in its benchmark interest rate to 4.25%. Individual Stock News 1. Leapmotor (09863.HK) received formal approval from the China Securities Regulatory Commission for its private placement, and FAW Group and Jinyi High-Tech Group's strategic investment was finalized. 2. Health160 (02656.HK)'s subsidiary signed a strategic cooperation framework agreement for AI computing power, with an estimated cooperation amount of approximately RMB 650 million. 3. Evergrande Auto (00708.HK) released its 2024 annual results: profit attributable to shareholders was RMB 6.269 billion, turning a loss into a profit year-on-year. 4. 51 Vision (06651.HK)'s integrated intelligent business has accumulated orders exceeding RMB 200 million, with over 90% of orders expected to be delivered within the year. 5. Haixi New Drug (02637.HK): The Phase I clinical trial of HX9428 for the treatment of nAMD has completed 24 weeks of treatment data observation, and the Phase II dose extension study has obtained interim clinical data. 6. PCCW (00008.HK): Completed the sale of an interest in a subsidiary. The sale of the target interest was completed on September 16, 2026, for a total consideration of US$209,452,500, paid in full in cash to Hong Kong Telecom Group. 7. Jianye Real Estate (00832.HK): In August 2026, the Group achieved contracted property sales of RMB572 million, a decrease of 12.9% year-on-year; contracted sales area of 93,663 square meters, a decrease of 7.3% year-on-year; and an average selling price per square meter of RMB6,107, a decrease of 6.1% year-on-year.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.